Literature DB >> 8609067

Relationship between cell-killing efficiency and number of platinum atoms binding to DNA, RNA, and protein molecules in HeLa cells treated with cis-diamine(glycolato)platinum(II).

M Akaboshi1, K Kawai, Y Kinashi, S Masunaga, K Ono.   

Abstract

HeLa S-3 cells were treated with 195m Pt-radiolabeled cis-diamine(glycolato)platinum(II) (254-S) under various conditions, and the relationship between the lethal effect and the numbers of Pt atoms binding to DNA, RNA, and proteins was examined. The mean lethal concentrations for the cells treated with 254-S at 37 degrees C for 0.5, 1, 2, and 3 h were 67.1, 47.0, 26.8 and 8.1 microM, respectively. Using identically treated cells, we determined the numbers of Pt atoms combined with DNA, RNA, and protein molecules after fractionation of the cells. In this way, the D 0 values (D 0, the dose that causes an average of one lethal event per member of the population), expressed as the drug concentration, could be related to the number of Pt atoms combined with each fraction. The efficiency of the Pt atom in killing the cells, expressed as the reciprocal of the D 0 values, was then calculated for each fraction. The results suggested that DNA was the primary target for cell killing by 254-S. The target volumes for DNA were 3.96, 4.97, and 11.77 x 10(4) nucleotides for 1-, 2-, and 3-h treated cells, respectively. In terms of the target volume, the cell-killing effects of 254-S were comparable to those of cis-diamine-dichloroplatinum(II) (CDDP), for which the target volumes under identical conditions were determined to be 5.17, 5.71, and 10.3x10 4 nucleotides, respectively, while in terms of the mean lethal dose (D 0), the cell-killing effects of 254-S were lower than those of CDDP by a factor of 5.1 (47.0/9.3), 4.0 (26.8/6.7), or 2.5 (8.1/3.2) for 1-, 2-, or 3-h treatment, respectively.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609067      PMCID: PMC5921063          DOI: 10.1111/j.1349-7006.1996.tb03156.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  10 in total

1.  Phosphorus compounds in animal tissues; a comparison of methods for the estimation of nucleic acids.

Authors:  W C SCHNEIDER
Journal:  J Biol Chem       Date:  1946-08       Impact factor: 5.157

2.  The mechanism of action of antitumor platinum compounds.

Authors:  J J Roberts; A J Thomson
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1979

3.  Determination of the target volume of HeLa cells treated with platinum-195 m radiolabeled cis-diammine(1, 1-cyclobutane-dicarboxylato)-platinum(II); comparison with cis- and trans-diamminedichloroplatinums(II).

Authors:  M Akaboshi; K Kawai; Y Tanaka; T Sumino; S Masunaga; K Ono; T Miyahara
Journal:  Nucl Med Biol       Date:  1994-10       Impact factor: 2.408

4.  Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary.

Authors:  E Wiltshaw; T Kroner
Journal:  Cancer Treat Rep       Date:  1976-01

Review 5.  Drugs five years later. Cisplatin.

Authors:  P J Loehrer; L H Einhorn
Journal:  Ann Intern Med       Date:  1984-05       Impact factor: 25.391

6.  cis-Platinum(II) amine complexes: some structure-activity relationships for immunosuppressive, nephrotoxic and gastrointestinal (side) effects in rats.

Authors:  J A Broomhead; D P Fairlie; M W Whitehouse
Journal:  Chem Biol Interact       Date:  1980-07       Impact factor: 5.192

7.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

Authors:  L H Einhorn; J Donohue
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

8.  Determination of the target volume of HeLa cells treated with platinum-195m radiolabeled trans-diaminedichloroplatinum(II): a comparison with cis-diaminedichloroplatinum(II).

Authors:  M Akaboshi; K Kawai; H Maki; K Akuta; Y Ujeno; K Ono; T Miyahara
Journal:  Nucl Med Biol       Date:  1993-05       Impact factor: 2.408

9.  The number of platinum atoms binding to DNA, RNA and protein molecules of HeLa cells treated with cisplatin at its mean lethal concentration.

Authors:  M Akaboshi; K Kawai; H Maki; K Akuta; Y Ujeno; T Miyahara
Journal:  Jpn J Cancer Res       Date:  1992-05

10.  Binding characteristics of (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-2-platin um(II) to DNA, RNA and protein molecules in HeLa cells and its lethal effect: comparison with cis- and trans-diamminedichloroplatinums(II).

Authors:  M Akaboshi; K Kawai; Y Ujeno; S Takada; T Miyahara
Journal:  Jpn J Cancer Res       Date:  1994-01
  10 in total
  2 in total

1.  Augmentation in chemosensitivity of intratumor quiescent cells by combined treatment with nicotinamide and mild hyperthermia.

Authors:  S Masunaga; K Ono; M Akaboshi; K Kawai; M Suzuki; Y Kinashi; M Takagaki
Journal:  Jpn J Cancer Res       Date:  1997-08

2.  Effects of bioreductive agents, tirapazamine and mitomycin C, on quiescent cell populations in solid tumors, evaluated by micronucleus assay.

Authors:  S Masunaga; K Ono; H Hori; T Shibata; M Suzuki; Y Kinashi; M Takagaki; M Akaboshi
Journal:  Jpn J Cancer Res       Date:  1997-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.